SEARCH

SEARCH BY CITATION

References

  • Alon, R., Kassner, P.D., Carr, M.W., Finger, E.B., Hemler, M.E. & Springer, T.A. (1995) The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. Journal of Cell Biology, 128, 12431253.
  • Baldini, L., Cro, L., Calori, R., Nobili, L., Silvestris, I. & Maiolo, A.T. (1992) Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. Blood, 79, 26882693.
  • Behr, S.I., Korinth, D. & Schriever, F. (1998) Differential adhesion pattern of B cell chronic lymphocytic leukemia cells. Leukemia, 12, 7177.
  • Burger, J.A., Burger, M. & Kipps, T.J. (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood, 94, 36583667.
  • Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell’Aquila, M. & Kipps, T.J. (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood, 96, 26552663.
  • Burger, J.A., Zvaifler, N.J., Tsukada, N., Firestein, G.S. & Kipps, T.J. (2001) Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. Journal of Clinical Investigation, 107, 305315.
  • Caligaris-Cappio, F. (2003) Role of the microenvironment in chronic lymphocytic leukemia. British Journal of Haematology, 123, 380388.
  • Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 17641775.
  • Csanaky, G., Matutes, E., Vass, J.A., Morilla, R. & Catovsky, D. (1997) Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia, 11, 408415.
  • Dewald, G., Brockman, S., Paternoster, S., Bone, N., O’Fallon, J., Allmer, C., James, C., Jelinek, D., Tschumper, R., Hanson, C., Pruthi, R., Witzig, T., Call, T. & Kay, N. (2003) Chromosome anomalies detected by interphase fluorscence in hybridization: correlation with significant biological features of chronic lymphocytic leukemia. British Journal of Haematology, 121, 287295.
  • Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 19101916.
  • Durig, J., Nuckel, H., Huttmann, A., Kruse, E., Holter, T., Halfmeyer, K., Fuhrer, A., Rudolph, R., Kalhori, N., Nusch, A., Deaglio, S., Malavasi, F., Moroy, T., Klein-Hitpass, L. & Duhrsen, U. (2003) Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood, 101, 27482755.
  • Eksioglu-Demiralp, E., Alpdogan, O., Aktan, M., Firatli, T., Ozturk, A., Budak, T., Bayik, M. & Akoglu, T. (1996) Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Leukemia, 10, 13311339.
  • De La Fuente, M.T., Casanova, B., Garcia-Gila, M., Silva, A. & Garcia-Pardo, A. (1999) Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. Leukemia, 13, 266274.
  • De La Fuente, M.T., Casanova, B., Moyano, J.V., Garcia-Gila, M., Sanz, L., Garcia-Marco, J., Silva, A. & Garcia-Pardo, A. (2002) Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. Journal of Leukocyte Biology, 71, 495502.
  • De La Fuente, M.T., Casanova, B., Cantero, E., Hernandez del Cerro, M., Garcia-Marco, J., Silva, A. & Garcia-Pardo, A. (2003) Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochemical and Biophysical Research Communications, 311, 708712.
  • Ghia, P., Granziero, L., Chilosi, M. & Caligaris-Cappio, F. (2002) Chronic B cell malignancies and bone marrow microenvironment. Seminars in Cancer Biology, 12, 149155.
  • Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. & Oscier, D.G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, 10231029.
  • Hayashida, K., Shimaoka, Y., Ochi, T. & Lipsky, P.E. (2000) Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. Journal of Immunology, 164, 11101116.
  • Hemler, M.E. (1990) VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annual Review of Immunology, 8, 365400.
  • Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., Stenson, M.J., Witzig, T.E., Tefferi, A. & Kay, N.E. (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. British Journal of Haematology, 115, 854861.
  • Jelinek, D.F., Tschumper, R.C., Stolovitzky, G.A., Iturria, S.J., Tu, Y., Lepre, J., Shah, N. & Kay, N.E. (2003) Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Molecular Cancer Research, 1, 346361.
  • Kay, N.E., Shanafelt, T.D., Strege, A.K., Lee, Y.K., Bone, N.D. & Raza, A. (2007) Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”. Leukemia Research, 31, 899906.
  • Koopman, G., Keehnen, R.M., Lindhout, E., Newman, W., Shimizu, Y., Van Seventer, G.A., De Groot, C. & Pals, S.T. (1994) Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. Journal of Immunology, 152, 37603767.
  • Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 14101416.
  • Lagneaux, L., Delforge, A., Bron, D., Bruyn, C.D. & Stryckmans, P. (1998) Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood, 91, 23872396.
  • Lagneaux, L., Delforge, A., De Bruyn, C., Bernier, M. & Bron, D. (1999) Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. Leukemia & Lymphoma, 35, 445453.
  • Lucio, P.J., Faria, M.T., Pinto, A.M., Da Silva, M.R., Correia Junior, M.E., Da Costa, R.J. & Parreira, A.B. (1998) Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders. Haematologica, 83, 104111.
  • Orchard, J., Ibbotson, R., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P., Hamblin, T., Staudt, L. & Oscier, D. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukemia. Lancet, 363, 105111.
  • Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, J.A. & Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 11771184.
  • Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. & Hoffbrand, A. (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 92, 97103.
  • Pedersen, I.M., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., Kipps, T.J., Choi, Y.S., Bennett, F. & Reed, J.C. (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood, 100, 17951801.
  • Pinto, A., Carbone, A., Gloghini, A., Marotta, G., Volpe, R. & Zagonel, V. (1993) Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders. Cancer, 72, 894904.
  • Pittner, B.T., Shanafelt, T.D., Kay, N.E. & Jelinek, D.F. (2005) CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia, 19, 22642272.
  • Plate, J.M., Long, B.W. & Kelkar, S.B. (2000) Role of beta2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells. Leukemia, 14, 3439.
  • Polman, C.H., O’Connor, P.W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D.H., Phillips, J.T., Lublin, F.D., Giovannoni, G., Wajgt, A., Toal, M., Lynn, F., Panzara, M.A. & Sandrock, A.W. (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. New England Journal of Medicine, 354, 899910.
  • Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. & Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine, 351, 893901.
  • Rassenti, L.Z., Neuberg, D., Huynh, L., Wierda, W., Gribben, J.G., Brown, J.R., Flinn, I.W., Rai, K.R., Byrd, J.C., Greaves, A.W. & Kipps, T.J. (2006) Relative value of CD38 and ZAP-70 vesrsus immunoglobulin mutation status in predicting early disease progression in chronic lymphocytic leukemia. Blood, 108, Abstract no. 2778.
  • Redondo-Munoz, J., Escobar-Diaz, E., Samaniego, R., Terol, M.J., Garcia-Marco, J.A. & Garcia-Pardo, A. (2006) MMP-9 in B-cell chronic lymphocytic leukemia is upregulated by {alpha}4{beta}1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood, 108, 31433151.
  • Romond, E.H., Perez, E.A., Bryant, J., Suman, V.J., Geyer, Jr, C.E., Davidson, N.E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P.A., Swain, S.M., Pisansky, T.M., Fehrenbacher, L., Kutteh, L.A., Vogel, V.G., Visscher, D.W., Yothers, G., Jenkins, R.B., Brown, A.M., Dakhil, S.R., Mamounas, E.P., Lingle, W.L., Klein, P.M., Ingle, J.N. & Wolmark, N. (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New England Journal of Medicine, 353, 16731684.
  • Rose, D.M., Han, J. & Ginsberg, M.H. (2002) Alpha4 integrins and the immune response. Immunological Reviews, 186, 118124.
  • Rudick, R.A., Stuart, W.H., Calabresi, P.A., Confavreux, C., Galetta, S.L., Radue, E.W., Lublin, F.D., Weinstock-Guttman, B., Wynn, D.R., Lynn, F., Panzara, M.A. & Sandrock, A.W. (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. New England Journal of Medicine, 354, 911923.
  • Sembries, S., Pahl, H., Stilgenbauer, S., Dohner, H. & Schriever, F. (1999) Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. Blood, 93, 624631.
  • Shanafelt, T.D., Geyer, S. & Kay, N. (2004) Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood, 103, 12021210.
  • Shanafelt, T.D., Witzig, T.E., Fink, S.R., Jenkins, R.B., Paternoster, S.F., Smoley, S.A., Stockero, K.J., Nast, D.M., Flynn, H.C., Tschumper, R.C., Geyer, S., Zent, C.S., Call, T.G., Jelinek, D.F., Kay, N.E. & Dewald, G.W. (2006a) Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. Journal of Clinical Oncology, 24, 46344641.
  • Shanafelt, T.D., Jelinek, D., Tschumper, R., Schwager, S., Nowakowski, G., DeWald, G.W. & Kay, N.E. (2006b) Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia. Journal of Clinical Oncology, 24, 32183219; author reply 3219–3220.
  • Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J. & Norton, L. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine, 344, 783792.
  • Till, K.J., Lin, K., Zuzel, M. & Cawley, J.C. (2002) The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood, 99, 29772984.
  • Till, K.J., Spiller, D.G., Harris, R.J., Chen, H., Zuzel, M. & Cawley, J.C. (2005) CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium. Blood, 105, 48134819.
  • Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O., Karlsson, K., Merup, M., Juliusson, G., Vilpo, J., Enblad, G., Sundstrom, C., Roos, G. & Rosenquist, R. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted V{lambda}2-14 gene usage and homologous CDR3s: implicating recognition of a common antigen epitope. Blood, 13, 13.
  • Vincent, A.M., Cawley, J.C. & Burthem, J. (1996) Integrin function in chronic lymphocytic leukemia. Blood, 87, 47804788.
  • Zucchetto, A., Sonego, P., Degan, M., Bomben, R., Dal Bo, M., Russo, S., Attadia, V., Rupolo, M., Buccisano, F., Del Principe, M.I., Del Poeta, G., Pucillo, C., Colombatti, A., Campanini, R. & Gattei, V. (2005) Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. Journal of Cellular Physiology, 204, 113123.
  • Zucchetto, A., Bomben, R., Dal Bo, M., Bulian, P., Benedetti, D., Nanni, P., Del Poeta, G., Degan, M. & Gattei, V. (2006a) CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia, 20, 523525.
  • Zucchetto, A., Bomben, R., Dal Bo, M., Sonego, P., Nanni, P., Rupolo, M., Bulian, P., Dal Maso, L., Del Poeta, G., Del Principe, M.I., Degan, M. & Gattei, V. (2006b) A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. Journal of Cellular Physiology, 207, 354363.